Related Experiment Videos

Dialysis-related amyloidosis

K Fukuda1, H Yamamoto

  • 1Department of Radiology, The Jikei University School of Medicine, 3--25--8 Nishi-shimbashi, Minato-ku, Tokyo, 105--8461, Japan.

Insights

Dialysis-related amyloidosis (DRA) is a complication of long-term hemodialysis caused by beta(2)-microglobulin deposition. Advanced imaging like MRI and ultrasound can detect soft tissue and spinal changes in DRA.

Area of Science:

  • Nephrology
  • Radiology
  • Biomedical Engineering

Background:

  • Dialysis-related amyloidosis (DRA) is a known complication in patients undergoing long-term hemodialysis.
  • It results from the accumulation of beta(2)-microglobulin, primarily affecting musculoskeletal tissues.

Purpose of the Study:

  • To review the diagnostic capabilities of various imaging modalities for Dialysis-related amyloidosis.
  • To highlight the effectiveness of MRI and ultrasound in detecting early and specific DRA manifestations.

Main Methods:

  • Review of literature on imaging findings in Dialysis-related amyloidosis.
  • Comparison of plain radiography, MRI, and ultrasound for DRA detection.

Main Results:

  • Plain radiography shows advanced bone erosions and cystic lesions in DRA but is insensitive to early changes.
  • Magnetic resonance imaging (MRI) and ultrasound are effective in detecting amyloid deposition in periarticular soft tissues.
  • These advanced imaging techniques are also valuable for evaluating spinal complications associated with DRA.

Conclusions:

  • While plain radiography reveals late-stage DRA, MRI and ultrasound offer superior visualization of early and soft tissue-related changes.
  • Advanced imaging modalities are crucial for comprehensive assessment and management of patients with Dialysis-related amyloidosis.

Related Concept Videos